Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-003484

Chief Executive Officer sold 28,700 shares at an average $21.39 ($613,843)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ciechanover Isaac E. Chief Executive Officer 2018-01-10 Sale −4,500 $19.64 $88,380 384,278 I
Ciechanover Isaac E. Chief Executive Officer 2018-01-10 Sale −4,100 $20.38 $83,558 380,178 I
Ciechanover Isaac E. Chief Executive Officer 2018-01-11 Sale −2,500 $21.49 $53,725 377,678 I
Ciechanover Isaac E. Chief Executive Officer 2018-01-11 Sale −17,500 $22.01 $385,175 360,178 I
Ciechanover Isaac E. Chief Executive Officer 2018-01-12 Sale −100 $30.05 $3,005 360,078 I
Open-market sales · 28,700 sh · avg $21.39 · $613,843
Loading xslF345X03/doc4.xml…